Naltrexone Accord (Naltrexone Hydrochloride)

Naltrexone works as a competitive antagonist at the mu‑opioid receptor. By occupying these receptors, it prevents both endogenous opioids and external opioid drugs from binding, thereby diminishing the rewarding sensations associated with alcohol and opioid use and helping to lower the desire to consume these substances.

The dosage of Naltrexone Accord is determined by the prescribing clinician based on the individual’s medical condition, response, and tolerability. Typical regimens may start with a low dose and be titrated, but the exact amount and schedule should always follow the prescriber’s instructions.

Safety data for Naltrexone Accord during pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives and risks with their healthcare provider.

To order Naltrexone Accord, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs), and import documentation.

Naltrexone differs from opioid agonist therapies such as methadone or buprenorphine because it blocks opioid receptors rather than activating them. Compared with acamprosate for alcohol dependence, naltrexone directly reduces the reward response, while acamprosate modulates glutamatergic pathways. Choice of therapy depends on patient history, comorbidities, and treatment goals.

Naltrexone Accord should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Naltrexone Accord is taken orally, usually with a full glass of water. It can be taken with or without food, but consistent administration with respect to meals helps maintain steady drug levels. Patients should follow the prescriber’s instructions regarding timing and any required fasting periods.

The most serious risks include potential liver injury, severe depression, suicidal thoughts, and allergic reactions such as rash or anaphylaxis. Patients should be monitored regularly for hepatic function and mental health changes, and any signs of severe adverse reactions should prompt immediate medical evaluation.

Naltrexone Accord should be avoided in individuals with acute hepatitis, severe liver impairment, or those currently using opioid analgesics, as it can precipitate withdrawal. Patients with known hypersensitivity to naltrexone or any of the tablet’s excipients should also not use this medication.